CALOTATUG GINISTINAG
UNII RA7UQ7N2QE

Substance Identification & Data

This profile provides standardized clinical and technical data for Calotatug Ginistinag, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RA7UQ7N2QE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2847102-44-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
RA7UQ7N2QE
CAS Registry Number
2847102-44-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CALOTATUG GINISTINAG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C190297
National Cancer Institute reference terminology for clinical and research data.
INN ID
12945
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Calotatug Ginistinag. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CALOTATUG GINISTINAG

Common Names & Synonyms

CALOTATUG GINISTINAG [INN]
IMMUNOGLOBULIN G1 (DE-447-LYSINE), ANTI-(HUMAN TYROSINE KINASE RECEPTOR HER2) (HUMAN MONOCLONAL XMT-1519 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL XMT-1519 .KAPPA.-CHAIN, DIMER, REDUCED, THIOETHER WITH 1,1'-((N5-((11S)-16-((5-(AMINOCARBONYL)-1-((2E)-4-(6-(AMINOCARBONYL)-2-(((4-ETHYL-2-METHYL-5-OXAZOLYL)CARBONYL)AMINO)-3H-IMIDAZO(4,5-B)PYRIDIN-3-YL)-2-BUTEN-1-YL)-2-(((4-ETHYL-2-METHYL-5-OXAZOLYL)CARBONYL)AMINO)-1H-BENZIMIDAZOL-7-YL)OXY)-11-METHYL-9,12-DIOXO-3,6,13-TRIOXA-10-AZAHEXADEC-1-YL)-N2-(2-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)ACETYL)-L-.ALPHA.-GLUTAMYLGLYCYLGLYCYLGLYCYLGLYCYL-27-AMINO-4,7,10,13,16,19,22,25-OCTAOXAHEPTACOSANOYL-L-GLUTAMOYL)DIIMINO)BIS(1-DEOXY-D-GLUCITOL)
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ERBB2 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2, EPIDERMAL GROWTH FACTOR RECEPTOR 2, EGFR2, HER2, HER-2, P185C-ERBB2, NEU, CD340)), HOMO SAPIENS MONOCLONAL ANTIBODY, CONJUGATED ON 8 CYSTEINYL RESIDUES TO A STING AGONIST, WITH A RATIO OF 1 TO 8

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus